PCIA
TMO icon

Prime Capital Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Prime Capital Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-800
Closed -$11.6K – 968
2024
Q2 		$11.6K Hold
800
– – ﹤0.01% 917
2024
Q1 		$12.8K Sell
800
-500
-38% -$281K ﹤0.01% 1000
2023
Q4 		$29.7K Buy
+1,300
New +$629K ﹤0.01% 946

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Prime Capital Investment Advisors's TMO Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, selling an estimated $4.41M and leaving 23,814 shares worth $11.9M. The position accounts for 0.12% of the portfolio, ranked #136.

Prime Capital Investment Advisors first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $19.7M in Q4 2025. 1,940 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Prime Capital Investment Advisors held 23,814 shares of Thermo Fisher Scientific worth $11.9M as of Q2 2026.
  • Prime Capital Investment Advisors sold 9,181 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.41M.
  • Thermo Fisher Scientific made up 0.12% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #136 holding.
  • Prime Capital Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
  • Prime Capital Investment Advisors's Thermo Fisher Scientific position peaked at $19.7M in Q4 2025.
  • 1,940 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.